Chemical Engineering @ChemengFiles.Com

In the framework of the scientific programs of the European Space Agency (ESA) has been announced for May 14 next Ariane 5 launch of a particularly awaited by the international scientific community.

In this event, the European launcher carried the two most complex satellite to date in Europe: Herschel and Planck. Be placed in an orbit at a distance of 1.5 million kilometers from earth, after a trip in the space of about four months. These new space telescopes will be able to provide information astrophysical unprecedented accuracy and an unprecedented about the universe, its origins and its evolution. The group Air Liquide, the world leader in cryogenics, has developed innovative technologies placed in the heart of these two scientific satellites.

In the framework of the scientific programs of the European Space Agency (ESA) has been announced for May 14 next Ariane 5 launch of a particularly awaited by the international scientific community.

In this event, the European launcher carried the two most complex satellite to date in Europe: Herschel and Planck. Be placed in an orbit at a distance of 1.5 million kilometers from earth, after a trip in the space of about four months. These new space telescopes will be able to provide information astrophysical unprecedented accuracy and an unprecedented about the universe, its origins and its evolution. The group Air Liquide, the world leader in cryogenics, has developed innovative technologies placed in the heart of these two scientific satellites.

Fujirebio Diagnostics, Inc. and Abbott have entered into a license agreement to develop a new test for ovarian cancer using automated diagnostic analyzers ARCHITECT (R) from Abbott. Under the agreement, Fujirebio Diagnostics to develop and manufacture the Abbott biomarker HE4, a simple blood test can help the risk stratification of women at high risk for ovarian cancer, a disease difficult to detect in its early stages.

Fujirebio Diagnostics, Inc. and Abbott have entered into a license agreement to develop a new test for ovarian cancer using automated diagnostic analyzers ARCHITECT (R) from Abbott. Under the agreement, Fujirebio Diagnostics to develop and manufacture the Abbott biomarker HE4, a simple blood test can help the risk stratification of women at high risk for ovarian cancer, a disease difficult to detect in its early stages.

Elsevier has announced that it begins to provide consistent guidelines for their internal divisions of pharmaceutical services in reprints of products, collections of articles or advertising on behalf of pharmaceutical companies. This initiative follows the internal review began when the company experienced a series of publications produced in Australia between 2000 and 2005 that had the name "journal of" but that it lacked adequate sponsorship presentations and

Given the numbers identified in the series of Australasia, the company has acted to ensure that all of its pharmaceutical services division of the world continue the practice of patronage and have consistent standards for the products of several reprint articles. Although these divisions of pharmaceutical services frequently reprinted articles revised Elsevier, manage separate from the division that publishes the central collection of the company of major research publications.

Elsevier has announced that it begins to provide consistent guidelines for their internal divisions of pharmaceutical services in reprints of products, collections of articles or advertising on behalf of pharmaceutical companies. This initiative follows the internal review began when the company experienced a series of publications produced in Australia between 2000 and 2005 that had the name "journal of" but that it lacked adequate sponsorship presentations and

Given the numbers identified in the series of Australasia, the company has acted to ensure that all of its pharmaceutical services division of the world continue the practice of patronage and have consistent standards for the products of several reprint articles. Although these divisions of pharmaceutical services frequently reprinted articles revised Elsevier, manage separate from the division that publishes the central collection of the company of major research publications.